ReviewCureus2026

The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review.

Jacky Xiao Feng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.